Literature DB >> 3781113

Functional reserve capacity of the exocrine pancreas.

P G Lankisch, B Lembcke, G Wemken, W Creutzfeldt.   

Abstract

The functional reserve capacity of the pancreas, as reflected by the absence of steatorrhea, was correlated with the results of a secretin-pancreozymin test (SPT) in 47 patients with exocrine pancreatic insufficiency due to chronic pancreatitis. The results indicate that a severe reduction in enzyme output (but not in bicarbonate concentration and output) is usually associated with steatorrhea. However, there were a number of patients with steatorrhea despite only moderate enzyme output impairment, while others had normal fat excretion but severely reduced enzyme secretion. Thus, the degree of impaired pancreatic function, as measured by the SPT, cannot be predicted by the presence of steatorrhea; vice versa, a moderately abnormal SPT does not exclude the presence of pancreatic steatorrhea. Therefore, for a sophisticated evaluation of the functional reserve capacity of the exocrine pancreas, both the SPT and fecal fat analysis are considered necessary. The correlation between impaired glucose tolerance and exocrine pancreatic function was poor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3781113     DOI: 10.1159/000199364

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  17 in total

Review 1.  Pancreatic enzyme replacement therapy.

Authors:  P Layer; J Keller; P G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2001-04

2.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

3.  Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C-labeled mixed triglyceride breath test.

Authors:  Seiko Hirono; Yoshiaki Murakami; Masaji Tani; Manabu Kawai; Ken-ichi Okada; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Naoya Nakagawa; Naru Kondo; Hiroki Yamaue
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

4.  Randomized prospective trial of the effect of induced hypergastrinemia on the prevention of pancreatic atrophy after pancreatoduodenectomy in humans.

Authors:  Jin-Young Jang; Sun-Whe Kim; Joon-Koo Han; Sang-Jae Park; Youn-Chan Park; Young Joon Ahn; Yong-Hyun Park
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

Review 5.  Chronic pancreatitis: A diagnostic dilemma.

Authors:  Sinead N Duggan; Hazel M Ní Chonchubhair; Oladapo Lawal; Donal B O'Connor; Kevin C Conlon
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 6.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 1. Secretagogues used in tests of pancreatic secretion.

Authors:  E J Boyd; K G Wormsley
Journal:  Int J Pancreatol       Date:  1987-06

Review 7.  The role of fecal elastase-1 in detecting exocrine pancreatic disease.

Authors:  John S Leeds; Kofi Oppong; David S Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05-31       Impact factor: 46.802

8.  Detection of pancreatic steatorrhea by oral pancreatic function tests.

Authors:  P G Lankisch; J Otto; J Brauneis; R Hilgers; B Lembcke
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

9.  Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy.

Authors:  M J Bruno; E A Rauws; F J Hoek; G N Tytgat
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

10.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.